Advanced Search (OLGA)

Gene: LHFPL4 (LHFPL tetraspan subfamily member 4) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

LHFPL4

Name:

LHFPL tetraspan subfamily member 4

RGD ID:

1604456

HGNC Page

HGNC:29568

Description:

Predicted to enable GABA receptor binding activity. Predicted to be involved in gamma-aminobutyric acid receptor clustering; regulation of inhibitory synapse assembly; and sensory perception of sound. Predicted to be located in dendrite and synapse. Predicted to be active in several cellular components, including GABA-ergic synapse; inhibitory synapse; and postsynaptic membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

GABAA receptor regulatory Lhfpl4; GARLH4; LHFP-like protein 4; lipoma HMGIC fusion partner-like 4; lipoma HMGIC fusion partner-like 4 protein; MGC133162; RP11-58B17.2

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	9,498,361 - 9,553,822 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	9,498,361 - 9,553,822 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	9,540,045 - 9,595,506 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	9,515,045 - 9,570,486 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	3	9,474,743 - 9,530,187 (-)	NCBI		Celera
Cytogenetic Map	3	p25.3	NCBI
HuRef	3	9,476,796 - 9,532,110 (-)	NCBI		HuRef
CHM1_1	3	9,490,268 - 9,545,714 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	9,490,279 - 9,545,747 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LHFPL4	Human	Atrioventricular Septal Defect 2		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Atrioventricular septal defect more ...	ClinVar	PMID:28492532
LHFPL4	Human	long QT syndrome		IAGP	(Homo sapiens) and (Homo sapiens)	8554872	ClinVar Annotator: match by term: Long QT syndrome	ClinVar	PMID:28492532
LHFPL4	Human	Neurodevelopmental Disorders		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder	ClinVar	PMID:25741868

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LHFPL4	Human	1,2-dimethylhydrazine	decreases expression	ISO	Lhfpl4 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in decreased expression of LHFPL4 mRNA	CTD	PMID:22206623
LHFPL4	Human	1,2-dimethylhydrazine	multiple interactions	ISO	Lhfpl4 (Mus musculus)	6480464	Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of LHFPL4 mRNA]	CTD	PMID:22206623
LHFPL4	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of LHFPL4 intron	CTD	PMID:30157460
LHFPL4	Human	aristolochic acid A	increases expression	EXP		6480464	aristolochic acid I results in increased expression of LHFPL4 mRNA	CTD	PMID:33212167
LHFPL4	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of LHFPL4 gene	CTD	PMID:25304211
LHFPL4	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of LHFPL4 gene	CTD	PMID:25304211
LHFPL4	Human	atrazine	increases expression	EXP		6480464	Atrazine results in increased expression of LHFPL4 mRNA	CTD	PMID:22378314
LHFPL4	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of LHFPL4 intron and Benzo(a)pyrene affects the methylation of LHFPL4 promoter	CTD	PMID:27901495 and PMID:30157460
LHFPL4	Human	benzo[a]pyrene	increases methylation	EXP		6480464	Benzo(a)pyrene results in increased methylation of LHFPL4 3' UTR and Benzo(a)pyrene results in increased methylation of LHFPL4 5' UTR	CTD	PMID:27901495
LHFPL4	Human	bis(2-ethylhexyl) phthalate	decreases expression	EXP		6480464	Diethylhexyl Phthalate results in decreased expression of LHFPL4 mRNA	CTD	PMID:31163220
LHFPL4	Human	bisphenol A	decreases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of LHFPL4 mRNA	CTD	PMID:25181051
LHFPL4	Human	bisphenol A	decreases expression	ISO	Lhfpl4 (Mus musculus)	6480464	bisphenol A results in decreased expression of LHFPL4 mRNA	CTD	PMID:32156529
LHFPL4	Human	bisphenol A	increases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	bisphenol A results in increased expression of LHFPL4 mRNA	CTD	PMID:29097150 and PMID:30816183
LHFPL4	Human	C60 fullerene	decreases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	fullerene C60 results in decreased expression of LHFPL4 mRNA	CTD	PMID:19167457
LHFPL4	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LHFPL4 mRNA	CTD	PMID:35301059
LHFPL4	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of LHFPL4 mRNA	CTD	PMID:38568856
LHFPL4	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LHFPL4 mRNA	CTD	PMID:35301059
LHFPL4	Human	choline	multiple interactions	ISO	Lhfpl4 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHFPL4 gene	CTD	PMID:20938992
LHFPL4	Human	copper atom	increases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	Copper deficiency results in increased expression of LHFPL4 mRNA	CTD	PMID:26033743
LHFPL4	Human	copper(0)	increases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	Copper deficiency results in increased expression of LHFPL4 mRNA	CTD	PMID:26033743
LHFPL4	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ...	CTD	PMID:27188386
LHFPL4	Human	folic acid	multiple interactions	ISO	Lhfpl4 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHFPL4 gene more ...	CTD	PMID:20938992 and PMID:22206623
LHFPL4	Human	genistein	increases expression	ISO	Lhfpl4 (Mus musculus)	6480464	Genistein results in increased expression of LHFPL4 mRNA	CTD	PMID:32186404
LHFPL4	Human	L-methionine	multiple interactions	ISO	Lhfpl4 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHFPL4 gene	CTD	PMID:20938992
LHFPL4	Human	lead diacetate	decreases expression	ISO	Lhfpl4 (Mus musculus)	6480464	lead acetate results in decreased expression of LHFPL4 mRNA	CTD	PMID:20542052
LHFPL4	Human	mercury dibromide	decreases expression	EXP		6480464	mercuric bromide results in decreased expression of LHFPL4 mRNA	CTD	PMID:26272509
LHFPL4	Human	mercury dibromide	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHFPL4 mRNA	CTD	PMID:27188386
LHFPL4	Human	methoxychlor	affects methylation	ISO	Lhfpl4 (Rattus norvegicus)	6480464	Methoxychlor affects the methylation of LHFPL4 gene	CTD	PMID:35440735
LHFPL4	Human	N-nitrosodiethylamine	increases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	Diethylnitrosamine results in increased expression of LHFPL4 mRNA	CTD	PMID:20360939
LHFPL4	Human	paracetamol	increases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	Acetaminophen results in increased expression of LHFPL4 mRNA	CTD	PMID:33387578
LHFPL4	Human	phenylmercury acetate	decreases expression	EXP		6480464	Phenylmercuric Acetate results in decreased expression of LHFPL4 mRNA	CTD	PMID:26272509
LHFPL4	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHFPL4 mRNA	CTD	PMID:27188386
LHFPL4	Human	pioglitazone	multiple interactions	ISO	Lhfpl4 (Mus musculus)	6480464	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LHFPL4 mRNA	CTD	PMID:27935865
LHFPL4	Human	resveratrol	multiple interactions	EXP		6480464	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LHFPL4 mRNA	CTD	PMID:23557933
LHFPL4	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ...	CTD	PMID:27188386
LHFPL4	Human	titanium dioxide	decreases methylation	ISO	Lhfpl4 (Mus musculus)	6480464	titanium dioxide results in decreased methylation of LHFPL4 gene	CTD	PMID:35295148
LHFPL4	Human	trichloroethene	increases expression	ISO	Lhfpl4 (Rattus norvegicus)	6480464	Trichloroethylene results in increased expression of LHFPL4 mRNA	CTD	PMID:33387578
LHFPL4	Human	triptonide	increases expression	ISO	Lhfpl4 (Mus musculus)	6480464	triptonide results in increased expression of LHFPL4 mRNA	CTD	PMID:33045310
LHFPL4	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of LHFPL4 gene	CTD	PMID:29154799
LHFPL4	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of LHFPL4 mRNA	CTD	PMID:25979313
LHFPL4	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of LHFPL4 mRNA	CTD	PMID:28001369

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LHFPL4	Human	gamma-aminobutyric acid receptor clustering	involved_in	ISS	UniProtKB:Q5U4E0	150520179		UniProt	GO_REF:0000024
LHFPL4	Human	gamma-aminobutyric acid receptor clustering	involved_in	IBA	MGI:3057108 and PANTHER:PTN002647993	150520179		GO_Central	GO_REF:0000033
LHFPL4	Human	gamma-aminobutyric acid receptor clustering	involved_in	IEA	UniProtKB:Q5U4E0 and ensembl:ENSMUSP00000124470	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	neurotransmitter receptor localization to postsynaptic specialization membrane	involved_in	IEA	UniProtKB:Q5U4E0 and ensembl:ENSMUSP00000124470	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	regulation of inhibitory synapse assembly	involved_in	IEA	UniProtKB:Q5U4E0 and ensembl:ENSMUSP00000124470	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	regulation of inhibitory synapse assembly	involved_in	ISS	UniProtKB:Q5U4E0	150520179		UniProt	GO_REF:0000024
LHFPL4	Human	sensory perception of sound	involved_in	IBA	FB:FBgn0262624 more ...	150520179		GO_Central	GO_REF:0000033

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LHFPL4	Human	cell projection	located_in	IEA	UniProtKB-KW:KW-0966	150520179		UniProt	GO_REF:0000043
LHFPL4	Human	dendrite	located_in	IEA	UniProtKB-SubCell:SL-0283	150520179		UniProt	GO_REF:0000044
LHFPL4	Human	GABA-ergic synapse	is_active_in	IEA	UniProtKB:Q5U4E0 and ensembl:ENSMUSP00000124470	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	inhibitory synapse	located_in	ISS	UniProtKB:Q5U4E0	150520179		UniProt	GO_REF:0000024
LHFPL4	Human	inhibitory synapse	located_in	IEA	UniProtKB:Q5U4E0 more ...	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	inhibitory synapse	is_active_in	IBA	MGI:3057108 more ...	150520179		GO_Central	GO_REF:0000033
LHFPL4	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
LHFPL4	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
LHFPL4	Human	plasma membrane	is_active_in	IBA	MGI:1915382 more ...	150520179		GO_Central	GO_REF:0000033
LHFPL4	Human	postsynaptic membrane	located_in	IEA	UniProtKB:Q5U4E0 and ensembl:ENSMUSP00000124470	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	postsynaptic membrane	is_active_in	IBA	MGI:3057108 and PANTHER:PTN002647993	150520179		GO_Central	GO_REF:0000033
LHFPL4	Human	postsynaptic membrane	located_in	IEA	UniProtKB-SubCell:SL-0219	150520179		UniProt	GO_REF:0000044
LHFPL4	Human	postsynaptic membrane	located_in	IEA	UniProtKB-KW:KW-0628	150520179		UniProt	GO_REF:0000043
LHFPL4	Human	postsynaptic membrane	located_in	ISS	UniProtKB:Q5U4E0	150520179		UniProt	GO_REF:0000024
LHFPL4	Human	postsynaptic specialization	is_active_in	IEA	UniProtKB:Q5U4E0 and ensembl:ENSMUSP00000124470	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	synapse	located_in	IEA	UniProtKB-KW:KW-0770	150520179		UniProt	GO_REF:0000043

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LHFPL4	Human	GABA receptor binding	enables	IBA	MGI:3057108 more ...	150520179		GO_Central	GO_REF:0000033
LHFPL4	Human	GABA receptor binding	enables	IEA	UniProtKB:Q5U4E0 more ...	150520179		Ensembl	GO_REF:0000107
LHFPL4	Human	protein binding	enables	IPI	UniProtKB:Q9Y6I9	150520179	PMID:32296183	IntAct	PMID:32296183
LHFPL4	Human	protein binding	enables	IPI	UniProtKB:P62812	150520179	PMID:28978485	UniProt	PMID:28978485

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
LHFPL4	Human	Prolonged QT interval		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Long QT syndrome	ClinVar	PMID:28492532
LHFPL4	Human	Prolonged QT interval		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Long QT syndrome	ClinVar	PMID:28492532

#	Reference Title	Reference Citation
1.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
2.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:12477932	PMID:15905332	PMID:20379614	PMID:21873635	PMID:28279354	PMID:28514442	PMID:28978485	PMID:32296183	PMID:33961781	PMID:36724073	PMID:37433992

LHFPL4
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	9,498,361 - 9,553,822 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	9,498,361 - 9,553,822 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	9,540,045 - 9,595,506 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	9,515,045 - 9,570,486 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	3	9,474,743 - 9,530,187 (-)	NCBI		Celera
Cytogenetic Map	3	p25.3	NCBI
HuRef	3	9,476,796 - 9,532,110 (-)	NCBI		HuRef
CHM1_1	3	9,490,268 - 9,545,714 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	9,490,279 - 9,545,747 (-)	NCBI		T2T-CHM13v2.0

Lhfpl4
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	6	113,145,048 - 113,172,345 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	6	113,145,051 - 113,172,345 (-)	Ensembl		GRCm39 Ensembl
GRCm38	6	113,168,087 - 113,195,384 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	6	113,168,090 - 113,195,384 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	6	113,118,081 - 113,145,378 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	6	113,135,401 - 113,161,161 (-)	NCBI		MGSCv36	mm8
Celera	6	114,996,909 - 115,024,142 (-)	NCBI		Celera
Cytogenetic Map	6	E3	NCBI
cM Map	6	52.74	NCBI

Lhfpl4
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	4	147,872,877 - 147,895,770 (-)	NCBI		GRCr8
mRatBN7.2	4	146,317,110 - 146,340,073 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	4	146,313,541 - 146,340,463 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	4	151,701,577 - 151,724,428 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	4	147,482,411 - 147,505,262 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	4	146,103,757 - 146,126,678 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	4	145,117,533 - 145,147,397 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	4	145,117,533 - 145,147,397 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	4	208,415,890 - 208,445,642 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	4	149,049,668 - 149,072,608 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	4	149,294,508 - 149,317,449 (-)	NCBI
Celera	4	134,877,048 - 134,898,925 (-)	NCBI		Celera
Cytogenetic Map	4	q42	NCBI

Lhfpl4
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955561	1,066,799 - 1,142,099 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955561	1,066,799 - 1,142,099 (-)	NCBI	ChiLan1.0	ChiLan1.0

LHFPL4
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	2	9,510,331 - 9,565,838 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	3	9,515,093 - 9,570,591 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	3	9,453,628 - 9,506,434 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	3	9,695,091 - 9,745,722 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	3	9,695,091 - 9,745,722 (-)	Ensembl	panpan1.1		panPan2

LHFPL4
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	20	8,630,981 - 8,663,918 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	20	8,630,747 - 8,660,389 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	20	8,664,027 - 8,696,484 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	20	8,660,390 - 8,693,304 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	20	8,659,943 - 8,693,283 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	20	8,382,860 - 8,415,261 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	20	8,727,665 - 8,760,738 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	20	8,701,291 - 8,734,265 (+)	NCBI		UU_Cfam_GSD_1.0

Lhfpl4
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404942	15,345,648 - 15,396,180 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936602	3,532,005 - 3,564,680 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936602	3,532,979 - 3,564,062 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

LHFPL4
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	13	65,869,652 - 65,919,781 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	13	65,867,124 - 65,920,887 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	13	72,937,834 - 72,987,503 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

LHFPL4
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	22	45,502,763 - 45,556,828 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
Vero_WHO_p1.0	NW_023666041	121,008,266 - 121,060,209 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Lhfpl4
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624731	4,194,321 - 4,222,105 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624731	4,194,321 - 4,222,400 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in LHFPL4
14 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 3p25.3(chr3:9221810-9727021)x3	copy number gain	See cases [RCV000050855]	Chr3:9221810..9727021 [GRCh38] Chr3:9263494..9768705 [GRCh37] Chr3:9238494..9743705 [NCBI36] Chr3:3p25.3	uncertain significance
GRCh38/hg38 3p26.3-25.3(chr3:52266-11089569)x1	copy number loss	See cases [RCV000051447]	Chr3:52266..11089569 [GRCh38] Chr3:93949..11131255 [GRCh37] Chr3:68949..11106255 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:63843-9507969)x1	copy number loss	See cases [RCV000051476]	Chr3:63843..9507969 [GRCh38] Chr3:105526..9549653 [GRCh37] Chr3:80526..9524653 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh38/hg38 3p25.3-25.2(chr3:8581778-12015238)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051480]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051480]\|See cases [RCV000051480]	Chr3:8581778..12015238 [GRCh38] Chr3:8623464..12056738 [GRCh37] Chr3:8598464..12031738 [NCBI36] Chr3:3p25.3-25.2	pathogenic
GRCh38/hg38 3p25.3(chr3:9393349-9956171)x1	copy number loss	See cases [RCV000051481]	Chr3:9393349..9956171 [GRCh38] Chr3:9435033..9997855 [GRCh37] Chr3:9410033..9972855 [NCBI36] Chr3:3p25.3	pathogenic
GRCh38/hg38 3p26.3-22.2(chr3:52266-37148076)x3	copy number gain	See cases [RCV000051097]	Chr3:52266..37148076 [GRCh38] Chr3:93949..37189567 [GRCh37] Chr3:68949..37164571 [NCBI36] Chr3:3p26.3-22.2	pathogenic
GRCh38/hg38 3p26.3-24.3(chr3:52066-20280127)x3	copy number gain	See cases [RCV000051690]	Chr3:52066..20280127 [GRCh38] Chr3:93749..20321619 [GRCh37] Chr3:68749..20296623 [NCBI36] Chr3:3p26.3-24.3	pathogenic
GRCh38/hg38 3p26.3-24.1(chr3:52266-29248782)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051718]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051718]\|See cases [RCV000051718]	Chr3:52266..29248782 [GRCh38] Chr3:93949..29290273 [GRCh37] Chr3:68949..29265277 [NCBI36] Chr3:3p26.3-24.1	pathogenic
GRCh38/hg38 3p26.3-24.3(chr3:63843-19510600)x3	copy number gain	See cases [RCV000051719]	Chr3:63843..19510600 [GRCh38] Chr3:105526..19552092 [GRCh37] Chr3:80526..19527096 [NCBI36] Chr3:3p26.3-24.3	pathogenic
NM_198560.2(LHFPL4):c.737G>A (p.Gly246Glu)	single nucleotide variant	Malignant melanoma [RCV000060876]	Chr3:9502218 [GRCh38] Chr3:9543902 [GRCh37] Chr3:9518902 [NCBI36] Chr3:3p25.3	not provided
GRCh38/hg38 3p26.1-25.3(chr3:8038727-11240931)x4	copy number gain	See cases [RCV000135641]	Chr3:8038727..11240931 [GRCh38] Chr3:8080414..11282617 [GRCh37] Chr3:8055414..11257617 [NCBI36] Chr3:3p26.1-25.3	likely pathogenic
GRCh38/hg38 3p25.3-25.2(chr3:9394874-11690612)x1	copy number loss	See cases [RCV000137433]	Chr3:9394874..11690612 [GRCh38] Chr3:9436558..11732086 [GRCh37] Chr3:9411558..11707086 [NCBI36] Chr3:3p25.3-25.2	pathogenic
GRCh38/hg38 3p26.1-25.2(chr3:7975734-12636917)x3	copy number gain	See cases [RCV000137309]	Chr3:7975734..12636917 [GRCh38] Chr3:8017421..12678416 [GRCh37] Chr3:7992421..12653416 [NCBI36] Chr3:3p26.1-25.2	likely pathogenic
GRCh38/hg38 3p25.3(chr3:8812036-9953438)x3	copy number gain	See cases [RCV000137329]	Chr3:8812036..9953438 [GRCh38] Chr3:8853722..9995122 [GRCh37] Chr3:8828722..9970122 [NCBI36] Chr3:3p25.3	uncertain significance
GRCh38/hg38 3p26.3-25.2(chr3:32241-12681483)x1	copy number loss	See cases [RCV000138143]	Chr3:32241..12681483 [GRCh38] Chr3:73914..12722982 [GRCh37] Chr3:48914..12697982 [NCBI36] Chr3:3p26.3-25.2	pathogenic
GRCh38/hg38 3p26.3-24.1(chr3:32241-30064208)x3	copy number gain	See cases [RCV000138004]	Chr3:32241..30064208 [GRCh38] Chr3:73914..30105699 [GRCh37] Chr3:48914..30080703 [NCBI36] Chr3:3p26.3-24.1	pathogenic
GRCh38/hg38 3p26.3-24.3(chr3:32241-20334387)x3	copy number gain	See cases [RCV000137941]	Chr3:32241..20334387 [GRCh38] Chr3:73914..20375879 [GRCh37] Chr3:48914..20350883 [NCBI36] Chr3:3p26.3-24.3	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:32241-11379835)x1	copy number loss	See cases [RCV000138376]	Chr3:32241..11379835 [GRCh38] Chr3:73914..11421309 [GRCh37] Chr3:48914..11396309 [NCBI36] Chr3:3p26.3-25.3	pathogenic\|likely benign
GRCh38/hg38 3p25.3(chr3:8941623-10151752)x3	copy number gain	See cases [RCV000138535]	Chr3:8941623..10151752 [GRCh38] Chr3:8983307..10193436 [GRCh37] Chr3:8958307..10168436 [NCBI36] Chr3:3p25.3	likely benign\|uncertain significance
GRCh38/hg38 3p25.3(chr3:9142303-9793982)x3	copy number gain	See cases [RCV000139348]	Chr3:9142303..9793982 [GRCh38] Chr3:9183987..9835666 [GRCh37] Chr3:9158987..9810666 [NCBI36] Chr3:3p25.3	uncertain significance
GRCh38/hg38 3p26.3-25.1(chr3:32241-13613818)x3	copy number gain	See cases [RCV000138946]	Chr3:32241..13613818 [GRCh38] Chr3:73914..13655318 [GRCh37] Chr3:48914..13630319 [NCBI36] Chr3:3p26.3-25.1	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:32241-9574994)x1	copy number loss	See cases [RCV000140239]	Chr3:32241..9574994 [GRCh38] Chr3:73914..9616678 [GRCh37] Chr3:48914..9591678 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh38/hg38 3p26.3-22.1(chr3:53308-41381521)x3	copy number gain	See cases [RCV000141810]	Chr3:53308..41381521 [GRCh38] Chr3:94991..41423012 [GRCh37] Chr3:69991..41398016 [NCBI36] Chr3:3p26.3-22.1	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:20213-11221602)x1	copy number loss	See cases [RCV000141731]	Chr3:20213..11221602 [GRCh38] Chr3:61891..11263288 [GRCh37] Chr3:36891..11238288 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:32241-10323124)x1	copy number loss	See cases [RCV000143325]	Chr3:32241..10323124 [GRCh38] Chr3:73914..10364808 [GRCh37] Chr3:48914..10339808 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:32241-10631310)x1	copy number loss	See cases [RCV000143173]	Chr3:32241..10631310 [GRCh38] Chr3:73914..10672995 [GRCh37] Chr3:48914..10647995 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh38/hg38 3p26.1-25.1(chr3:7356110-14360442)x3	copy number gain	See cases [RCV000143766]	Chr3:7356110..14360442 [GRCh38] Chr3:7397797..14401942 [GRCh37] Chr3:7372797..14376946 [NCBI36] Chr3:3p26.1-25.1	pathogenic
GRCh38/hg38 3p26.3-25.3(chr3:688897-11051142)x1	copy number loss	See cases [RCV000143706]	Chr3:688897..11051142 [GRCh38] Chr3:730581..11092828 [GRCh37] Chr3:705581..11067828 [NCBI36] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p25.3(chr3:9405337-10168892)x3	copy number gain	See cases [RCV000240180]	Chr3:9405337..10168892 [GRCh37] Chr3:3p25.3	likely pathogenic
GRCh37/hg19 3p25.3-25.2(chr3:8922160-12338637)x1	copy number loss	See cases [RCV000240139]	Chr3:8922160..12338637 [GRCh37] Chr3:3p25.3-25.2	pathogenic
GRCh37/hg19 3p25.3(chr3:9518530-9547865)x3	copy number gain	See cases [RCV000240499]	Chr3:9518530..9547865 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p26.3-24.2(chr3:61891-24432821)x3	copy number gain	See cases [RCV000447247]	Chr3:61891..24432821 [GRCh37] Chr3:3p26.3-24.2	pathogenic
GRCh37/hg19 3p26.3-22.2(chr3:61891-36710181)x3	copy number gain	See cases [RCV000448528]	Chr3:61891..36710181 [GRCh37] Chr3:3p26.3-22.2	pathogenic
GRCh37/hg19 3p26.1-25.3(chr3:6842555-10153209)x1	copy number loss	See cases [RCV000448839]	Chr3:6842555..10153209 [GRCh37] Chr3:3p26.1-25.3	pathogenic
GRCh37/hg19 3p26.3-22.3(chr3:61891-33958201)x3	copy number gain	See cases [RCV000510429]	Chr3:61891..33958201 [GRCh37] Chr3:3p26.3-22.3	pathogenic
GRCh37/hg19 3p25.3(chr3:9421663-9574327)x1	copy number loss	See cases [RCV000511930]	Chr3:9421663..9574327 [GRCh37] Chr3:3p25.3	likely pathogenic
GRCh37/hg19 3p26.3-22.2(chr3:61891-37459464)x3	copy number gain	See cases [RCV000511463]	Chr3:61891..37459464 [GRCh37] Chr3:3p26.3-22.2	pathogenic
GRCh37/hg19 3p26.3-25.2(chr3:61891-12575409)x1	copy number loss	See cases [RCV000511155]	Chr3:61891..12575409 [GRCh37] Chr3:3p26.3-25.2	pathogenic
GRCh37/hg19 3p25.3(chr3:9371390-9599828)x4	copy number gain	See cases [RCV000510969]	Chr3:9371390..9599828 [GRCh37] Chr3:3p25.3	likely benign
NM_198560.3(LHFPL4):c.268A>G (p.Ser90Gly)	single nucleotide variant	not specified [RCV004310539]	Chr3:9552412 [GRCh38] Chr3:9594096 [GRCh37] Chr3:3p25.3	likely benign
NM_198560.3(LHFPL4):c.164A>G (p.Lys55Arg)	single nucleotide variant	not specified [RCV004307132]	Chr3:9552516 [GRCh38] Chr3:9594200 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3	copy number gain	See cases [RCV000511055]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)	copy number gain	See cases [RCV000512358]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-25.3(chr3:61891-10104842)x1	copy number loss	not provided [RCV000682180]	Chr3:61891..10104842 [GRCh37] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p26.3-24.3(chr3:1897972-19519085)x3	copy number gain	not provided [RCV000682215]	Chr3:1897972..19519085 [GRCh37] Chr3:3p26.3-24.3	pathogenic
GRCh37/hg19 3p26.1-24.3(chr3:5173870-16760262)x3	copy number gain	not provided [RCV000682233]	Chr3:5173870..16760262 [GRCh37] Chr3:3p26.1-24.3	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3	copy number gain	not provided [RCV000742133]	Chr3:60174..197948027 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3	copy number gain	not provided [RCV000742138]	Chr3:61495..197838262 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p25.3(chr3:9547959-9898582)x1	copy number loss	not provided [RCV000742227]	Chr3:9547959..9898582 [GRCh37] Chr3:3p25.3	benign
GRCh37/hg19 3p25.3(chr3:9561205-9568424)x1	copy number loss	not provided [RCV000742228]	Chr3:9561205..9568424 [GRCh37] Chr3:3p25.3	benign
GRCh37/hg19 3p25.3(chr3:8883205-9954034)x3	copy number gain	not provided [RCV000848799]	Chr3:8883205..9954034 [GRCh37] Chr3:3p25.3	uncertain significance
Single allele	duplication	Neurodevelopmental disorder [RCV000787461]	Chr3:9453917..12015126 [GRCh37] Chr3:3p25.3-25.2	uncertain significance
GRCh37/hg19 3p26.1-25.3(chr3:7172720-9545741)x3	copy number gain	not provided [RCV001005411]	Chr3:7172720..9545741 [GRCh37] Chr3:3p26.1-25.3	uncertain significance
GRCh37/hg19 3p26.3-25.3(chr3:61891-10287825)x1	copy number loss	not provided [RCV001007530]	Chr3:61891..10287825 [GRCh37] Chr3:3p26.3-25.3	pathogenic
NC_000003.11:g.(?_8775553)_(9730776_?)dup	duplication	Long QT syndrome [RCV001033330]	Chr3:8775553..9730776 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p26.3-25.3(chr3:60931-10687964)x3	copy number gain	not provided [RCV002468435]	Chr3:60931..10687964 [GRCh37] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p26.3-25.3(chr3:61892-11679509)x1	copy number loss	not provided [RCV002473616]	Chr3:61892..11679509 [GRCh37] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p26.1-25.3(chr3:7694117-9546173)x1	copy number loss	See cases [RCV002285054]	Chr3:7694117..9546173 [GRCh37] Chr3:3p26.1-25.3	pathogenic
GRCh37/hg19 3p25.3(chr3:9501646-9991928)x4	copy number gain	not provided [RCV001795849]	Chr3:9501646..9991928 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p26.3-22.2(chr3:61891-36710181)	copy number gain	not specified [RCV002053300]	Chr3:61891..36710181 [GRCh37] Chr3:3p26.3-22.2	pathogenic
GRCh37/hg19 3p26.3-24.2(chr3:61891-24432821)	copy number gain	not specified [RCV002053299]	Chr3:61891..24432821 [GRCh37] Chr3:3p26.3-24.2	pathogenic
GRCh37/hg19 3p26.3-25.3(chr3:61891-9797094)	copy number loss	not specified [RCV002053298]	Chr3:61891..9797094 [GRCh37] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p26.1-25.3(chr3:6842555-10153209)	copy number loss	not specified [RCV002053327]	Chr3:6842555..10153209 [GRCh37] Chr3:3p26.1-25.3	pathogenic
NC_000003.11:g.(?_7782024)_(11078652_?)dup	duplication	Atrioventricular septal defect, susceptibility to, 2 [RCV001875165]	Chr3:7782024..11078652 [GRCh37] Chr3:3p26.1-25.3	uncertain significance
NC_000003.11:g.(?_8775563)_(9986075_?)dup	duplication	Long QT syndrome [RCV001923348]	Chr3:8775563..9986075 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.340T>G (p.Ser114Ala)	single nucleotide variant	not specified [RCV004310540]	Chr3:9552340 [GRCh38] Chr3:9594024 [GRCh37] Chr3:3p25.3	likely benign
GRCh37/hg19 3p26.3-25.3(chr3:61892-9769457)x1	copy number loss	not provided [RCV002472587]	Chr3:61892..9769457 [GRCh37] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p26.3-25.3(chr3:61892-9899605)x1	copy number loss	not provided [RCV002472571]	Chr3:61892..9899605 [GRCh37] Chr3:3p26.3-25.3	pathogenic
GRCh37/hg19 3p26.2-25.3(chr3:3691505-9917651)x1	copy number loss	3p- syndrome [RCV003330127]	Chr3:3691505..9917651 [GRCh37] Chr3:3p26.2-25.3	pathogenic
GRCh37/hg19 3p26.3-24.1(chr3:310747-28297447)x3	copy number gain	not provided [RCV003484107]	Chr3:310747..28297447 [GRCh37] Chr3:3p26.3-24.1	pathogenic
Single allele	deletion	not provided [RCV003448703]	Chr3:61435..9944653 [GRCh37] Chr3:3p26.3-25.3	pathogenic
NM_198560.3(LHFPL4):c.378G>T (p.Lys126Asn)	single nucleotide variant	not specified [RCV004414989]	Chr3:9552302 [GRCh38] Chr3:9593986 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.289T>C (p.Phe97Leu)	single nucleotide variant	not specified [RCV004414985]	Chr3:9552391 [GRCh38] Chr3:9594075 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p26.1-25.3(chr3:6306331-11468530)x1	copy number loss	not specified [RCV003986402]	Chr3:6306331..11468530 [GRCh37] Chr3:3p26.1-25.3	pathogenic
GRCh37/hg19 3p26.3-22.3(chr3:61891-33946644)x3	copy number gain	not specified [RCV003986437]	Chr3:61891..33946644 [GRCh37] Chr3:3p26.3-22.3	pathogenic
NM_198560.3(LHFPL4):c.418G>A (p.Val140Ile)	single nucleotide variant	not specified [RCV004414990]	Chr3:9506192 [GRCh38] Chr3:9547876 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.628A>C (p.Lys210Gln)	single nucleotide variant	not specified [RCV004414991]	Chr3:9505982 [GRCh38] Chr3:9547666 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.370G>C (p.Val124Leu)	single nucleotide variant	not specified [RCV004414986]	Chr3:9552310 [GRCh38] Chr3:9593994 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p26.3-22.3(chr3:60000-34461438)x3	copy number gain	not provided [RCV004577500]	Chr3:60000..34461438 [GRCh37] Chr3:3p26.3-22.3	pathogenic
NC_000003.11:g.(?_9470623)_(11078652_?)dup	duplication	not provided [RCV004582249]	Chr3:9470623..11078652 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.335G>T (p.Cys112Phe)	single nucleotide variant	not specified [RCV004642450]	Chr3:9552345 [GRCh38] Chr3:9594029 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.624G>C (p.Glu208Asp)	single nucleotide variant	not specified [RCV004642449]	Chr3:9505986 [GRCh38] Chr3:9547670 [GRCh37] Chr3:3p25.3	uncertain significance
NM_198560.3(LHFPL4):c.44A>G (p.Tyr15Cys)	single nucleotide variant	not specified [RCV004941791]	Chr3:9552636 [GRCh38] Chr3:9594320 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p25.3(chr3:9503081-10315429)x3	copy number gain	not provided [RCV004819459]	Chr3:9503081..10315429 [GRCh37] Chr3:3p25.3	uncertain significance
GRCh37/hg19 3p25.3(chr3:9506164-9561205)x1	copy number loss	not provided [RCV004819335]	Chr3:9506164..9561205 [GRCh37] Chr3:3p25.3	pathogenic
NM_198560.3(LHFPL4):c.632C>T (p.Pro211Leu)	single nucleotide variant	not specified [RCV004941792]	Chr3:9505978 [GRCh38] Chr3:9547662 [GRCh37] Chr3:3p25.3	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	886
Count of miRNA genes:	562
Interacting mature miRNAs:	622
Transcripts:	ENST00000287585, ENST00000495730, ENST00000498277
Prediction methods:	Microtar, Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597271513	GWAS1367587_H	cysteine-rich with EGF-like domain protein 1 measurement QTL GWAS1367587 (human)		3e-11	cysteine-rich with EGF-like domain protein 1 measurement		3	9515054	9515055	Human
2316345	GLUCO224_H	Glucose level QTL 224 (human)	1.27	0.008	Glucose level		3	1	21543441	Human

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system	visual system
1148	2265	2581	2036	4864	1467	1908	419	1298	259	2143	5746	5505	26	3701	617	1547	1392	166	1


RefSeq Transcripts	NM_198560	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017006359	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017006360	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054346461	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC018506	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC026194	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AY278320	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC029607	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC113964	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471055	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000287585 ⟹ ENSP00000287585

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	9,498,361 - 9,553,822 (-)	Ensembl

Ensembl Acc Id:

ENST00000495730

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	9,550,612 - 9,552,307 (-)	Ensembl

Ensembl Acc Id:

ENST00000498277

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	9,552,572 - 9,553,795 (-)	Ensembl

RefSeq Acc Id:

NM_198560 ⟹ NP_940962

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	9,498,361 - 9,553,822 (-)	NCBI
GRCh37	3	9,540,045 - 9,595,486 (-)	RGD
Build 36	3	9,515,045 - 9,570,486 (-)	NCBI Archive
Celera	3	9,474,743 - 9,530,187 (-)	RGD
HuRef	3	9,476,796 - 9,532,110 (-)	ENTREZGENE
CHM1_1	3	9,490,268 - 9,545,714 (-)	NCBI
T2T-CHM13v2.0	3	9,490,279 - 9,545,747 (-)	NCBI

Sequence:

show sequence

GCGCCCCGGGGAGAACCCGAGCAAGATGGAGGCCGCGCAGAGGCCGCCGCCTGGGCCGAGGCAGCCGCTGCTGGGAGCGCCGAGCCGCGGCGCCTAGGCCGTGCCAGTCCCGGATCCGCTGCCTCCGG
CCGTGCCCAGCAGCTCCCAGACGCCCCCAGCTCTGCCCCAGGCCCCGCCCTCGCGGGTTCCTTGACTCAGGGCCGCTTCTCGCGTGCGTCCCCAGCTCCCGCCCGGCAGCCCGGCGCTCCGTCCCGGG
CCGGCGGCCCCCGCCAGCCGCCGCCGCCGCCGGCCCCGCCTCCGGGCACCATGCTGCCCTCGCAGGAGGCCTCCAAGCTCTACCACGAGCACTACATGCGGAACTCGCGGGCCATCGGCGTGCTGTGG
GCCATCTTCACCATCTGCTTCGCCATCATCAACGTGGTGGTCTTCATCCAGCCCTACTGGGTGGGCGACAGCGTGAGCACCCCCAAGCCTGGCTACTTCGGCCTCTTCCACTACTGCGTGGGCAGCGG
GCTGGCGGGCCGCGAGCTCACCTGCCGGGGCTCCTTCACCGACTTCAGCACCATCCCGTCCAGCGCCTTCAAGGCGGCCGCCTTCTTCGTGCTGCTCTCCATGGTGCTGATCCTCGGCTGCATCACCT
GCTTTTCGCTTTTCTTCTTCTGCAACACGGCTACGGTCTACAAGATCTGCGCCTGGATGCAGCTCTTGGCAGCTCTGTGCCTCGTCCTGGGCTGCATGATCTTTCCTGATGGCTGGGATGCCGAGACC
ATCCGGGACATGTGTGGGGCCAAGACGGGGAAGTACTCCCTGGGGGACTGTTCAGTGCGCTGGGCATACATCCTGGCCATCATCGGCATCCTCAACGCCCTCATCCTCTCCTTCCTCGCCTTCGTGCT
GGGCAACCGGCAAACAGACCTGCTGCAGGAGGAGCTCAAGCCGGAGAACAAAGATTTTGTGGGCTCTACAGTAAGCTCCGTGTTGCGGCCCGGGGGTGATGTCTCTGGATGGGGAGTCCTTCCCTGCC
CCGTGGCTCACTCACAGGGACCCTGAAAGGCCAGGATCACAGCCCAGTAATTGGCCTGACCTCAGCTTGTCCTGCCTTCTGCCCTCTCGTCACTCCATTCAAGCTCTGAGGGAAGACCCTGATCTCAG
ACTTACTTCTCACCGACTACCCTGCAAGCTCCAGGCTTTGAGGAGAGGAAAGCCTGGATGTGGCCTGGGGGAGAGGAGAGGCCCTCCAAACCTTGGGAGGGTCTAATTCTTGCTCCTCCCTCAATTTG
ACCTAAGGGAGCCTGCATCTGCGTAGGCCCTTGGGCTTCTCCTCTCCTCTCTAGACTGGCCTGGAGGTCCCTGCAGATCCCCAGGGAGAGCGGAGCTGTAGTTCCAGCTCCCCAGGCCCCCTCAGTCT
GGAGGGCTGCCGCCTGGCTGTATCCGCACCTCTTCTGGTCCCTGCCTCTTCAAGAAATTTATTCTAGATACTGCTCCAGGGTGGGCTGGACTCTTTCCTACTTTTTTTTTTTTTCTTTTTTGGCTGAT
GTTGGTTCCACCACATCTGCCACAAAGCTCCAGGTGCCACCAGTCTCCCCTGGGACCTCCTCTGCTCCATTCCGGCCTGCTCCCAGCTCACCCTGAGGGAGAGCTGCACCGAGGGATGCACAGGGCCC
TGCTGTCAGCTGCAGACCGGGGCCCTGATCAGCCCAGAGTCAGAAAAGACTTTCAGGCTCTGGAGGTAGCGGGAGGGGGTACGTGGCCTCGGCAGTTGGAGCTTAGAAGCTGCTCAGCCCGGGCTGGC
CTGGCCTCCTCTTCCTCTCTGCTGGAACATCTCACTGATGACTGAGCCCTTGACCTTGGCCTCTTTTGCCCAGGCCTCCTCTCTGCTGGGATGTCTCACCAATGACTGGACCCTTGACCCTGGCCTGT
TTTGTACAGCACAGACTTCTTGGCCCTGTTGTCAGGGTTGGGGGTGTGGAGGGGACCCCAGAGGTGGGGAGTTGGGGGATGCATTACCCCTTCTGCCCCTTTTCATGCCCTCCATACCCCAGGCGTCT
ACCAAGGGCAGAGACTGTCTTGTCTCTTTGATACTTTTCTGCATAACTTGAACTTGCAGGTCATCTCTGAACAGGGTACCCCTGTCCCCCTTCCTAAGCCTTGTTACCCTGTCCCAGCCTCTTCCTCC
TCCTGGCCCACCTCTCGCCTTGCGATATGCCCAGGGTCTGCACCTATGGGCAGTGCTTGGAGCCGAGGCATGAGTGTATGTGTATGTGGGTGAAATGTGTGTGCGTGTGTGTGCGCGTGTGAGCGTGT
GTGTGTGTGTGTGTGTTGGGGGACAGGTGAGAAGTTTCTCCCCCCTCCACCCACTGTGGGGGCGTCTCCCTTCCCCTTGGCAGGGAGCAGGTGAGGGAGACTCCTGGTATTTTTTGAACACCCGTCAT
TCCCCTGTGGGTCTGGCGGCAGAGCCATCTCTCCCGGGGAGCCTCCCTGCCCTGGGGCCTGGACAGCTCCCTCAGCACTAGTTGCTGGTGCAGACCGGCTTCGTCCAGCGCCCCCTCCTGGCGGCCTG
GACCTGCAGGGAAGGGGCGGTGCCCTGCAGGATGCCAGGGGAAGCCGCCTCGGGCCTCGGCGGAGGGGAGAGGGTCGCTTGAGCGCCATGTGTTTGCCAACCTTGTGTTCATTTCCACAGGACTTGGA
CCTGAGAGTTAGGGTTTCCAAGAAAGACCCTAGAAGTCCCCTGCCTGTCTCCCCACTCTGGACCCTAGCCGGAATCAGATGTTGGGACCTAGTGGGTTCCTGCCACCTGGAACTTACCAAGTCCCGAC
TTCACTCCTCCACTTACTCCTCCCGGGCAAAGCCTCCCCGCAGTGCTCTGGTCCCAGCGCTGGGCTCCCCTTCCCCGCCGGCGCCTTCCCGGACAGTCCAGTCGGCCTGGGGTAGGGGCGCTGCGGGA
CAGAGGGTCCGAGTTAAATGCGGGAGGATGCGGGAGCCCCGTGGGAGGGAGTTGGGGTAGGAGGGAGTTCCTCAAAGATGCAAACCAAGCCCAGCGTTGGAGGGGGAGAGCAGAGTTAGGAGAGAGTG
AGGGGAGGGGCGCAGCAAGCGACTGGGAATGGGAGAAGACACTGGGGTGAGGAGAAGAGGGGTGCAGAGACAGGGAGATGAGAGATGATTGGAGAAGGAGCGAGGGGGACGCACAGGCACAGAGAAAC
AGCGCGAGGAGGAGAGATCGAGAGAGACGGGGCAGAGGTGGAGAGAGATGAGAGACCAGCTGAGAGGCTGCCCGAGAGCTTGGGGTGGGGGAGGGGAAATGGATGAAAAGGCGGAAAAAGGACTCGGG
AGCGGGGAAGAGGTAAATGGAGATGTGGGTTGGGGGCAAGAATGGGATGCAGAGGAAGGAGAGGAGGATGAAGGAGCCAGGATGCGGGGCAGTGGGGAGGGGGTTGCTATCTGGGCACTGGGTGAGGG
GAGAGCTTGTTCCCCCAAGGACGCCTGCCACCAGGTGTCCTTGCCACACCTTGTTCCCCAAGGACACCCACCAAACCTGTGCCCTGGTGCGGGGGATAGAACTGACCTTTCAGAGGCTGGAGGCCCGG
GGCACAGGCAGCCAAGGCCGCATCCTTTTGGGAAGAACTGGAGTGAAGGAAGCCACTTCAGAGGACGTAGTGGGTCCAGCTGACTTAGGAGTGGGTCAGCGCCGGGTGGAGAGGAGGGAGGCTAGTTC
CCTGGTGGGGTAGCCTGGCAACATTCCCATTCCACCGCACCTGGCCAGCTGCCATCTTGGCAGAGCCAGGGGGAGATGCACCAGGGAGTTTGGAGTCAGGAAGGCAGAGTTGTGTGGGCTGAAGTCTG
CGGGAACCCCAGGGTGACACAGGCAAGGGGTAGAAGTCAGAGTGGGGACCAAACCATAGACTGGGGCCCTGGGTTCTGCAGAGGTGTGGATGGGGCAGGTGGCAGGTGCTCCAGTGGGGGCCCCAGGT
GAGGCCCTGATGGCCCTCCTGGGGCAATAAAGACATCATGGGAAGGGGGCTTTGTGGTTTGCCTCTGCTCTCGTCGGGCGATCTGGCTTTAGCCTTCAGGAGGAGGTAAGCAGAGGAGATCAGTGCCT
GTTTCTGACCCCAGGAGGGCCTTGTTGGGCTCCAACCTAGAGCCTTCCGGCTTCAGGTCCCAAGAGAAGTCCCCCCCTAACTGTGACCCCCCTAACTGTGATCAGGGGTCTGCCATTGCCCGCTTTTC
TCTGCCTGATCTGGGGACTCAGGAGAGGCCACGGCAGCCACAGCCTAGGGGTGGTTCAGTCCCTGGCCCACAGTCTGGTCAGTTGAGTCCTTCTGGGAACCGGGGCTATGAAAACTTTCGTCTTTGGG
GACCGGTACCCATGAAGGAAAACTTTCCTGAGGGGGTGAGGACCAAAGAATCAAGATCCTTTTCAGGCCTGATAGCCAAGATGATGAGAACTTTTAGATAAGGCTGTGGGGAGAGTCCCTGGCCTTTT
GAGCATCCTGCTTGGGCACACGGGGAATAACCTTTCTCCAGCTTCCAGTGTGAACTGAGAAAGAGAAAGGGAAACCCTGTCTTTGGAGAAGCTGGGATGTTCCCAGCACCAGAAACTTCTGCAGGCCC
CTGCCTGGCCCACGGCTAACCTTTGGGTGGGACTGGAGTTTCCTGAACAGGGAACAAGGGAGCCTTCCGCAGAGCTCTGATGGGCAGGCCTCCGAGGGCCTGTGCTGTGTGCTGTTAGGATAGCTTGG
TGTTGTCTATACCCCATTAGTAAGTTTTGTCTGAGTGTGTCCTCGCTGTTCATTGTCTAATTTGGTAACATTTATTTTGGTCCTGACCCCTTCTGCTGCTGCTGGGTTTAAGCTTCAGTGCAGGTGGA
ATGACATTCAAATAAAGAAACACTTTCTATCACCCA

hide sequence

RefSeq Acc Id:

XM_017006360 ⟹ XP_016861849

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	9,549,858 - 9,552,847 (-)	NCBI

Sequence:

show sequence

CTCCTCGCGGGCCCCGCTGCTCACCGGCCCCGGTCTTTCGTTCCTTTGGCCTGGAAACCCCCTC
TCTCCAACCCTGGCCCGCCAATCCTAGGCTCCCTCCAGCCTACCTCCAGCCCTGGCTTCTGAGGACAGCCCCCCCTTCCTCGCCCCGTGTCCAGCAGTCCCAGCCCCCGATCCCGCTCTAGCTGTATC
CTAATTCTGCCACTTTGCCCTCTTAGACCCTCATACCAGCCCCCATTCCCCGTCCCAGCCCCCATATTACCTTCCCAACCACCCAGTCCCAGCCTCTTAAATTCCCTCTTCCCCCATCCTAGAAGCGC
CCACCACCGCCTCATAGTCCCTTGCTAGACACCCAATACCAGACCTCCTTCTACCCCTTAATACCAGTCCCCAAATTCCCTTCTGAGCTCCCTAAATTCAGCCCCTCTGCTAGTCCTCCAACACCAGT
CTCCAGCCTCCATTCCACCTCCCCTTGTCCCCTCCTACTCCCGTAATACCAGCTCTCAAACCCCCTCCCCAACTCCCCCATGGCCACTTTCAAGCACCTCCCCCCGCACTTCCAGGTCTCATATCCCC
ATCCTAGGCGCCCCCCAACTTTCTCATGGCCCCCTCCTAGGCCCCCCAGTAGGAGACCTTTGCCAGTCCCCCTAGACACGGCCTCAACACTCTCATGACCCCTTCCTCTCTCCCTTAGCAGCTCCCAG
ACGCCCCCAGCTCTGCCCCAGGCCCCGCCCTCGCGGGTTCCTTGACTCAGGGCCGCTTCTCGCGTGCGTCCCCAGCTCCCGCCCGGCAGCCCGGCGCTCCGTCCCGGGCCGGCGGCCCCCGCCAGCCG
CCGCCGCCGCCGGCCCCGCCTCCGGGCACCATGCTGCCCTCGCAGGAGGCCTCCAAGCTCTACCACGAGCACTACATGCGGAACTCGCGGGCCATCGGCGTGCTGTGGGCCATCTTCACCATCTGCTT
CGCCATCATCAACGTGGTGGTCTTCATCCAGCCCTACTGGGTGGGCGACAGCGTGAGCACCCCCAAGCCTGGCTACTTCGGCCTCTTCCACTACTGCGTGGGCAGCGGGCTGGCGGGCCGCGAGCTCA
CCTGCCGGGGCTCCTTCACCGACTTCAGCACCATCCCGTCCAGCGCCTTCAAGGCGGCCGCCTTCTTCGTGCTGCTCTCCATGGTGCTGATCCTCGGCTGCATCACCTGCTTTTCGCTTTTCTTCTTC
TGCAACACGGCTACGGTCTACAAGATCTGCGCCTGGATGCAGCTCTTGGCAGGAGGAATGTAACTTTTGGAAATGGCTGGAAGTCACTCCAGATCAAGTATAGAGAATACGATGGGTCATCAAATTGA
TAATTGTCACTTGGAATGACAGCCAAGGTGTGAGGACAAAGTCATGAGGCTGGTCTGTTTCCACAAGAGGACTTTTACAAATCCAGGGAGGAATTACTGCCTCATTGGAAGAATTGCCCAAACTCCTA
AAAGGACTATTTTGAAGAAGGCAGATGTGGACATTCTAATGGGCTTGTTTCAAATTCATCTCACCCAACTCAATTTAGATGTGGATCTTTGAAGAGGGTGGGAAAGGTGAACTATAGGATATGGGGGA
TATGGCTCCATACTTCTCTGTGGTACCCAGGGAGGTGATATTATGTATTTCTATTCTATTTCTCCTGCAAAGGCAAGCTGGAATCCTCAACTCATCAACCTTAATTTGGAGTCTGCAGATGGGTTGCT
GACCTCTTGGCTTTCAAATTCTCTGTAATCTGTGTGGGTTTAATCCTGGGGATTTGATGAATTGTCCAACAACCCCCATATAATAATAGAATTTCAGGCACCTTAGAGATCAGCTCCTTCAAATCCCA
CCTTCCCCTCCCCCTGTTTTAGAGAGAGGAAACTGAGTATAGAGATGGGAAGGGCTTACTTGAGGTCACACAGCTGTTAAGGGAGGAAGCTAGTTCTACAGCCGGGGGTCCTTGACTTCTGGCCCAGG
GCACTTTTGCTTGCATTACTGCCCCACCCATGTGGGCTGAGGGGGCAGTTGGCAGAGTTGAGCAGTTTATTCCATTTTGTTCAGAGATTTCTGAGTTCTCTGGGTGAGTGACTGATTCACTTTGCTTA
ATAAAGTGACACCAGGCCAGAAGCCAGACCACTGGACTACGAGTCTTGGGGTGGGGGTTCTTGGCTGACTTGGGTCTGTGACTCACCATGCAGTGTTAAGTAAGCCTTTTAGTTTAAATCTCAATTTC
CCATTTGTACAATAGGGGACTGGGAGCAGGTAGAT

hide sequence

RefSeq Acc Id:

XM_054346461 ⟹ XP_054202436

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	9,541,604 - 9,544,772 (-)	NCBI


Protein RefSeqs	NP_940962	(Get FASTA)	NCBI Sequence Viewer
	XP_016861849	(Get FASTA)	NCBI Sequence Viewer
	XP_054202436	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAP37013	(Get FASTA)	NCBI Sequence Viewer
	EAW63964	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000287585
	ENSP00000287585.6
GenBank Protein	Q7Z7J7	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_940962 ⟸ NM_198560

- UniProtKB:

A6NH76 (UniProtKB/Swiss-Prot), Q29RV7 (UniProtKB/Swiss-Prot), Q7Z7J7 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MLPSQEASKLYHEHYMRNSRAIGVLWAIFTICFAIINVVVFIQPYWVGDSVSTPKPGYFGLFHYCVGSGLAGRELTCRGSFTDFSTIPSSAFKAAAFFVLLSMVLILGCITCFSLFFFCNTATVYKIC
AWMQLLAALCLVLGCMIFPDGWDAETIRDMCGAKTGKYSLGDCSVRWAYILAIIGILNALILSFLAFVLGNRQTDLLQEELKPENKDFVGSTVSSVLRPGGDVSGWGVLPCPVAHSQGP

hide sequence

RefSeq Acc Id:	XP_016861849 ⟸ XM_017006360
- Peptide Label:	isoform X1
- Sequence:	show sequence MLPSQEASKLYHEHYMRNSRAIGVLWAIFTICFAIINVVVFIQPYWVGDSVSTPKPGYFGLFHYCVGSGLAGRELTCRGSFTDFSTIPSSAFKAAAFFVLLSMVLILGCITCFSLFFFCNTATVYKIC AWMQLLAGGM hide sequence

Ensembl Acc Id:

ENSP00000287585 ⟸ ENST00000287585

RefSeq Acc Id:	XP_054202436 ⟸ XM_054346461
- Peptide Label:	isoform X1

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q7Z7J7-F1-model_v2	AlphaFold	Q7Z7J7	1-247	view protein structure

RGD ID:

6863458

Promoter ID:

EPDNEW_H4894

Type:

initiation region

Name:

LHFPL4_1

Description:

lipoma HMGIC fusion partner-like 4

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	9,553,812 - 9,553,872	EPDNEW

Database	Acc Id	Source(s)
COSMIC	LHFPL4	COSMIC
Ensembl Genes	ENSG00000156959	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000287585	ENTREZGENE
	ENST00000287585.8	UniProtKB/Swiss-Prot
GTEx	ENSG00000156959	GTEx
HGNC ID	HGNC:29568	ENTREZGENE
Human Proteome Map	LHFPL4	Human Proteome Map
InterPro	LHFPL	UniProtKB/Swiss-Prot
KEGG Report	hsa:375323	UniProtKB/Swiss-Prot
NCBI Gene	375323	ENTREZGENE
OMIM	610240	OMIM
PANTHER	LHFPL TETRASPAN SUBFAMILY MEMBER 4 PROTEIN	UniProtKB/Swiss-Prot
	PTHR12489	UniProtKB/Swiss-Prot
Pfam	L_HMGIC_fpl	UniProtKB/Swiss-Prot
PharmGKB	PA166351940	PharmGKB
UniProt	A6NH76	ENTREZGENE
	LHPL4_HUMAN	UniProtKB/Swiss-Prot
	Q29RV7	ENTREZGENE
	Q7Z7J7	ENTREZGENE
UniProt Secondary	A6NH76	UniProtKB/Swiss-Prot
	Q29RV7	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2017-06-27	LHFPL4	LHFPL tetraspan subfamily member 4		lipoma HMGIC fusion partner-like 4	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar